Evidence map›Paper›PMID 36925875›Full record

ArticleFrontiers in health services2022

An Opportunity to Harmonise the Approach to Patients' Care Pathways for Rare and Complex Diseases: RarERN Path™.

Rosaria Talarico, Diana Marinello, Sara Cannizzo, Ilaria Palla, Simone Ticciati, Andrea Gaglioti, Andrzej Rys, Carlo Milli, Domenica Taruscio, Marta Mosca and 1 more

Open access · diamondFull text read
In one paragraph

Article in Frontiers in health services, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Rosaria TalaricoRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Diana MarinelloRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Sara CannizzoInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Ilaria PallaInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Simone TicciatiRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Andrea GagliotiRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Andrzej RysDG Sante, Brussels, Belgium.
Carlo MilliAdministrative Unit Chief, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Marta MoscaRheumatology Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
Giuseppe TurchettiInstitute of Management, Scuola Superiore Sant'Anna, Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITScuola Superiore Sant'Anna · ITIstituto Superiore di Sanità · ITDirectorate-General for Health and Food Safety · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a matter of fact, organisation always matters when discussing about healthcare, since it is fundamental in order to ensure the delivery of the most appropriate care to patients in the most appropriate way. Unfortunately, the pandemic brought by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) imposed a huge reorganisation of the healthcare systems, with several repercussions on the care of several chronic conditions, that were in many cases discontinued. This was the case of rare diseases (RDs), conditions that even under normal circumstances can experience diagnostic delays and difficulties in receiving appropriate care. The context of the European Reference Networks (ERNs) represents one of the most appropriate settings for the creation of organisational reference models for patient care pathways (PCP). As a matter of fact, the main mission of ERNs is to improve the care of patients with RDs in Europe through a patient-centred approach, thanks to real multistakeholder involvement. For this reason, in the last years, an extensive effort has been made towards the creation of a methodological approach aimed at providing organisational reference models for PCP in RDs across the different Member States. In fact, in order to develop the reference model, a structured methodology was created to enable the design of the PCP based on a deep sharing of expertise on high-quality care and characterised by a strong patient-centred approach: RarERN Path™. Among the different stakeholders that need to be involved in planning strategic actions to ensure care also during an emergency, patients' representatives, healthcare professionals, hospital managers, and experts in healthcare organisations play a crucial role.

Indexed as

healthcare systemorganisation of carepatients' care pathwaysrare diseasesRarERN Path™

Identifiers

PMID36925875
PMCPMC10012666
OpenAlexW4285084567

What OpenQuestion holds

Textfull text, public
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.